Progesterone receptor antagonist provides palliative effects for uterine leiomyoma through a Bcl-2/Beclin1-dependent mechanism

Uterine leiomyoma is the most common benign smooth muscle tumor of uterus in women of reproductive age, with a high lifetime incidence. Nowadays, the exploration on the pharmacotherapies, such as progesterone receptor antagonist (PRA) requires more attention. Hence, the current study aimed to examin...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lindong, Feng, Quanling, Wang, Zhiting, Liu, Pingping, Cui, Shihong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646233/
https://www.ncbi.nlm.nih.gov/pubmed/31262976
http://dx.doi.org/10.1042/BSR20190094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6646233/
https://www.ncbi.nlm.nih.gov/pubmed/31262976
http://dx.doi.org/10.1042/BSR20190094

Ejemplares similares